• IN A NUTSHELL

    UNICOM is about improved patient safety and better healthcare for all. This European Commission supported Innovation Action focuses on implementing the International Organization for Standardization (ISO) suite of IDMP (IDentification of Medicinal and pharmaceutical Products) standards. Work will involve further development, testing, implementation and diffusion of these standards for

    Read More
  • KEY CHALLENGES

    Most resource-rich countries maintain at least basic national (electronic) repositories and data bases of medicinal products which have gone through the stipulated regulatory national process to be marketed in that national healthcare system. Unfortunately, these uncoordinated national regulatory procedures have resulted in a host of unintended results and impacts endangering patient safety and hindering better healthcare service delivery, particularly in international contexts:
    Read More
  • OBJECTIVES

    UNICOM supports

    • regulatory processes of National Medicinal Products Authorities (NCAs) & the European Medicines Agency (EMA)
    • global pharmacovigilance
    • advancing cross-border digital health, particularly ePrescription, services
    • better healthcare, public health, medical research (e.g. Big Data analytics, AI applications)

    Core objectives focus on:

    • Adaptation and implementation of IDMP at EU and NCA level
    • Adaptation of Member States cross-border digital health services (ePrescription; Patient Summary…) to IDMP
    • Exploration and implementation of IDMP for pharmacovigilance reporting, Medicinal Product Dictionaries (MPDs), digital healthcare support services, patient empowerment
    Read More
  • VISION

    UNICOM is dedicated to

    • improving patient safety globally
    • facilitating better healthcare for all

     

  • CONTEXT

    The univocal identification of medicinal products is a global challenge. By going it alone, countries hinder the free flow of detailed, interoperable medicine information in the European Union, across the Atlantic, and globally. The UNICOM project joins forces with other stakeholders in our health systems to spearhead solving this challenge. It will accelerate the further diffusion of ISO IDMP standards (Identification of Medicinal and pharmaceutical Products).
  • MISSION

    UNICOM supports and enables the univocal identification of medicinal and pharmaceutical products by facilitating and accelerating the

    •  further development,
    •  implementation, and
    •  diffusion of ISO IDMP standards (IDentification of Medicinal and pharmaceutical Products)

    across European health systems.

  • UNICOM ACTION LINES

    To achieve the objectives envisaged and reach the outcomes foreseen, UNICOM is organised along three closely interrelated vertical action lines:

      • Implementation of IDMP  at EU /National MPs data base level
      • Adaptation of cross-border digital health services
      • Exploration for pharmacovigilance services, Medicinal Product Dictionaries [MPDs], healthcare services, patient empowerment, Big Data etc.

      These three action lines are supported by two horizontal activity clusters:

      • Further development of IDMP standards and implementation support
      • Socio-economic impact assessment and sustainability strategies, scientific coordination, project management, awareness raising and dissemination.
  • ESTABLISHING A SEAMLESS IDMP DATA VALUE CHAIN

    UNICOM will help to break down barriers hindering the free flow of detailed, semantically coded interoperable drug information across the globe.
    Read More
  • ACTOR AND STAKEHOLDER INVOLVMENT

    Core IDMP data value chain actors are consortium partners (26 National Drug and eHealth Authorities, Standard Development Organisations (SDOs), providers of cross-border ePrescription services, clinicians, patients, and many others).

    Further stakeholders are involved through their associations or as experts (via an Advisory Board, expert workshops, meetings & conferences etc.)

  • BENEFITS TO STAKEHOLDERS AND SOCIETY

    The impact and benefits for all stakeholders directly involved in the medicines data value chain, but also for health systems and societies will be multi-faceted and very substantial:
    Read More
  • GLOBAL OUTREACH

    The project assembles consortium partners from

    • 15 European Union member states
    • The United Kingdom and Norway
    • The United States of America

    Through various consortium partners, UNICOM may also reach out to similar authorities and organisations on other continents once concrete results and lessons learned become available.

  • TRANS-ATLANTIC COOPERATION

    As part of its activities, UNICOM undertakes activities around IDMP to foster trans-Atlantic cooperation in the spirit of the “Memorandum of Understanding between The United States Department of Health and Human Services and the European Commission on Cooperation Surrounding Health Related Information and Communication Technologies”.
  • SUPERVISION

  • DURATION

    Unicom will run for four years. Official start of this innovation action was 1 December 2019. The project is expected to end on 30 November 2023.
  • BUDGET

    The official budget amounts to around € 21 million. European Commission (EC) funding is € 19 m; it is provided in the context of the European Horizon 2020 research and innovation programme under grant agreement No 875299. This support is gratefully acknowledged by all participants and stakeholders involved in UNICOM.
    Read More

LATEST NEWS

LATEST TWEETS